Erratum to: Antiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw.
作者信息
Yoneda Toshiyuki, Hagino Hiroshi, Sugimoto Toshitsugu, Ohta Hiroaki, Takahashi Shunji, Soen Satoshi, Taguchi Akira, Nagata Toshihiko, Urade Masahiro, Shibahara Takahiko, Toyosawa Satoru
机构信息
Division of Hematology and Oncology, Indiana University School of Medicine, Indianapolis, USA.
The Japanese Society for Bone and Mineral Research, Kyoto, Japan.
出版信息
J Bone Miner Metab. 2017 Jan;35(1):20. doi: 10.1007/s00774-017-0816-9.
PMID:28120102
Abstract
摘要
相似文献
1
Erratum to: Antiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw.勘误：《抗吸收剂相关颌骨坏死：日本颌骨坏死联合委员会2017年立场文件》
J Bone Miner Metab. 2017 Jan;35(1):20. doi: 10.1007/s00774-017-0816-9.
2
[Recent treatment for medication-related osteonecrosis of the jaw].[颌骨药物相关性骨坏死的近期治疗]
Clin Calcium. 2016 Apr;26(4):612-21.
3
Issues with the surgical treatment of antiresorptive agent-related osteonecrosis of the jaws.抗吸收剂相关性颌骨坏死的手术治疗问题。
Oral Dis. 2018 Mar;24(1-2):52-56. doi: 10.1111/odi.12783.
4
Antiresorptive Agent-Related Osteonecrosis of the Jaw (ARONJ): A Twist of Fate in the Bone.抗吸收剂相关颌骨骨坏死（ARONJ）：骨骼中的命运转折。
Tohoku J Exp Med. 2019 Feb;247(2):75-86. doi: 10.1620/tjem.247.75.
5
Antiresorptive drug-related osteonecrosis of the jaw.抗吸收药物相关的颌骨坏死
Dent Clin North Am. 2014 Apr;58(2):369-84. doi: 10.1016/j.cden.2013.12.006.
6
Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review.与非抗吸收药物相关的颌骨坏死：系统评价。
Support Care Cancer. 2019 Feb;27(2):383-394. doi: 10.1007/s00520-018-4501-x. Epub 2018 Oct 23.
7
Diagnosis and Staging of Medication-Related Osteonecrosis of the Jaw.药物相关性颌骨坏死的诊断与分期
Oral Maxillofac Surg Clin North Am. 2015 Nov;27(4):479-87. doi: 10.1016/j.coms.2015.06.008. Epub 2015 Aug 18.
8
Osteonecrosis of jaw beyond antiresorptive (bone-targeted) agents: new horizons in oncology.抗骨吸收（靶向骨）药物之外的颌骨骨坏死：肿瘤学的新视野
Expert Opin Drug Saf. 2016 Jul;15(7):925-35. doi: 10.1080/14740338.2016.1177021. Epub 2016 May 3.
9
The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors.药物性颌骨坏死的发生率及其相关危险因素。
Oral Maxillofac Surg Clin North Am. 2015 Nov;27(4):509-16. doi: 10.1016/j.coms.2015.06.003. Epub 2015 Sep 9.
10
Osteonecrosis of the jaw related to everolimus: a case report.与依维莫司相关的颌骨骨坏死：一例报告
Br J Oral Maxillofac Surg. 2013 Dec;51(8):e302-4. doi: 10.1016/j.bjoms.2013.09.008. Epub 2013 Oct 2.
引用本文的文献
1
Imaging modalities for drug-related osteonecrosis of the jaw (2), Overview of the position paper on medication-related osteonecrosis of the jaw and the current status of the MRONJ in Japan.颌骨药物相关性骨坏死的影像学检查方法（2），颌骨药物相关性骨坏死立场文件概述及日本颌骨药物相关性骨坏死的现状
Jpn Dent Sci Rev. 2019 Nov;55(1):71-75. doi: 10.1016/j.jdsr.2018.11.003. Epub 2019 Mar 18.
2
Evaluation of medication-related osteonecrosis of the jaw using the Japanese Adverse Drug Event Report database.使用日本药品不良事件报告数据库评估药物相关性颌骨坏死
Ther Clin Risk Manag. 2018 Dec 24;15:59-64. doi: 10.2147/TCRM.S176620. eCollection 2019.
Zotero 插件